Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
CARDIOVASCULAR SAFETY OF REVEFENACIN FOR NEBULIZATION: A REVIEW OF RANDOMIZED CONTROLLED TRIAL DATA
Home
Publications
CARDIOVASCULAR SAFETY OF REVEFENACIN FOR NEBULIZATION: A REVIEW OF RANDOMIZED CONTROLLED TRIAL DATA
CARDIOVASCULAR SAFETY OF REVEFENACIN FOR NEBULIZATION: A REVIEW OF RANDOMIZED CONTROLLED TRIAL DATA
Authors:
JD
James Donohue
James Donohue
GF
Gregory Feldman
Gregory Feldman
SS
Sanjay Sethi
Sanjay Sethi
MB
Marie Borin
Marie Borin
CB
Chris Barnes
Chris Barnes
BD
Borje Darpo
Borje Darpo
SP
Srikanth Pendyala
Srikanth Pendyala
DB
David Bourdet
David Bourdet
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Publisher website
Google Scholar
1 October 2018
journal article
conference paper
Published by
Elsevier
in
Chest
Vol. 154
(4)
,
734A-735A
DOI:
10.1016/j.chest.2018.08.664
Abstract
No abstract available
Keywords
MACE
LAMA
Cited
Cited by 2 articles
Scroll to top